Atlas Trials

Evaluate Safety, Tolerability and Pharmacokinetics of Fadanafil (XZP-5849)in Chinese Healthy Adult Male Subjects

Clinical trial NCT04312568 · COMPLETED

Trial details

NCT number
NCT04312568
Sponsor
Sihuan Pharmaceutical Holdings Group Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subject
Start date
2018-08-10
Primary completion
2018-12-07
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.